Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wunderlich

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Cell Death & Disease|May 15, 2015
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent mannerN Werthmöller, B Frey, R Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1976
Temporary inhibition of antibody-dependent, cell-mediated cytotoxicity by pretreatment of human attacking cells with ammonium chlorideI Yust, R W Smith, J R Wunderlich, et al.
Clinical and Experimental Immunology|August 1, 1975
Complement-dependent and cell-dependent antiplatelet humoral antibody in sera from multi-transfused patientsJ S Macdonald, J R Wunderlich, I Yust, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1973
Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cellsI Yust, J R Wunderlich, D L Mann, et al.
International Journal of Cancer|July 15, 1985
In vitro and in vivo antitumor activity of lymphokine-induced cytotoxic cellsC C Ting, J R Wunderlich, M E Hargrove, et al.
Journal of Psychiatric Research|June 19, 2004
Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?Kenneth R Evans, Terrence Sills, Glen R Wunderlich, et al.
Journal of General Internal Medicine|May 17, 2022
Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids?Jeffrey R Wunderlich, Rachel S Engelberg, Babak Tofighi, et al.
Tissue Antigens|July 11, 1975
Anti-HL-A7 lymphocyte-dependent antibodyE B Rosenberg, G N Rogentine, J Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1971
Enhanced immunogenicity of chemically-coated syngeneic tumor cellsW J Martin, J R Wunderlich, F Fletcher, et al.
Developmental Biology|July 1, 1985
Major changes in gene expression occur during at least four stages of development of Dictyostelium discoideumJ A Cardelli, D A Knecht, R Wunderlich, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Cell Death & Disease|May 15, 2015
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent mannerN Werthmöller, B Frey, R Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1976
Temporary inhibition of antibody-dependent, cell-mediated cytotoxicity by pretreatment of human attacking cells with ammonium chlorideI Yust, R W Smith, J R Wunderlich, et al.
Clinical and Experimental Immunology|August 1, 1975
Complement-dependent and cell-dependent antiplatelet humoral antibody in sera from multi-transfused patientsJ S Macdonald, J R Wunderlich, I Yust, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1973
Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cellsI Yust, J R Wunderlich, D L Mann, et al.
International Journal of Cancer|July 15, 1985
In vitro and in vivo antitumor activity of lymphokine-induced cytotoxic cellsC C Ting, J R Wunderlich, M E Hargrove, et al.
Journal of Psychiatric Research|June 19, 2004
Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?Kenneth R Evans, Terrence Sills, Glen R Wunderlich, et al.
Journal of General Internal Medicine|May 17, 2022
Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids?Jeffrey R Wunderlich, Rachel S Engelberg, Babak Tofighi, et al.
Tissue Antigens|July 11, 1975
Anti-HL-A7 lymphocyte-dependent antibodyE B Rosenberg, G N Rogentine, J Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1971
Enhanced immunogenicity of chemically-coated syngeneic tumor cellsW J Martin, J R Wunderlich, F Fletcher, et al.
Developmental Biology|July 1, 1985
Major changes in gene expression occur during at least four stages of development of Dictyostelium discoideumJ A Cardelli, D A Knecht, R Wunderlich, et al.
Pageof 15